Wenming Chen

Capital University — United States

Medicine · Health Sciences

31h-index4.3kcitations137works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(45), Cancer-related molecular mechanisms research(24), Legume Nitrogen Fixing Symbiosis(21), Protein Degradation and Inhibitors(17), Peptidase Inhibition and Analysis(15)

Publications136 total

Plasma cell development-based prediction of prognosis and treatment response in individual multiple myeloma
MedScience·2025
Daratumumab-based therapy for newly diagnosed multiple myeloma patients with renal impairment：a multicenter retrospective study from China
Blood·2025
A multivariable prediction model for early mortality in multiple myeloma patients with renal impairment
Blood·2025
MBS314, a GPRC5DxBCMAxCD3 trispecific antibody, in relapsed/refractory multiple myeloma (RRMM): Updated results from a Phase 1 dose escalation study
Blood·2025Open Access
Long-term follow-up of zevor-cel in patients with relapsed/refractory multiple myeloma
Blood Advances·2025Open Access
Pretreatment hemoglobin, myeloma subtype, and induction regimens as independent prognostic factors for survival after autologous stem cell transplantation in multiple myeloma: a retrospective cohort study
Hematology·2025Open Access
Sustainable and effective degradation of high concentration of aniline by acetylguanidine activated persulfate
Environmental Geochemistry and Health·2025
Pretreatment hemoglobin, myeloma subtype, and induction regimens as independent prognostic factors for survival after autologous stem cell transplantation in multiple myeloma: A retrospective cohort study
Transplant Immunology·2025
Serum proteome profiling identified thrombospondin-1 and lactoferrin as biomarkers of relapsed multiple myeloma
Frontiers in Medicine·2025· 1 citedOpen Access
Pan-Pacific Multiple Myeloma (MM) Working Group Guidelines and Recommendations for CD38 Monoclonal Antibody-Based Quadruplet Therapy and Management in Clinical Practice for Newly Diagnosed MM
Clinical Lymphoma Myeloma & Leukemia·2025
Long Term Follow-Up of Zevor-Cel in Patients with Relapsed/Refractory Multiple Myeloma
Clinical Lymphoma Myeloma & Leukemia·2025
Real-World Outcomes of Equecabtagene Autoleucel, the First Fully Human BCMA-Targeted CAR-T Therapy, in 150 Patients with Multiple Myeloma (MM): A Multicenter Experience from China
Clinical Lymphoma Myeloma & Leukemia·2025
Consensus Guidelines and Recommendations for the anti-CD38-based Therapy in Clinical Practice for Relapsed/Refractory Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working Group
Clinical Hematology International·2025Open Access
Systemic capillary leak syndrome associated with smouldering multiple myeloma treated by bortezomib plus dexamethasone: A case report
British Journal of Haematology·2025
Imaging in plasma cell disorders—consensus recommendations of the Asian myeloma network bone imaging workgroup
The Lancet Regional Health - Western Pacific·2025· 2 citedOpen Access
Consensus Guidelines and Recommendations for The CD38 Monoclonal Antibody-based Quadruplet Therapy and Management in Clinical Practice for Newly Diagnosed Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working Group
Clinical Hematology International·2025Open Access
Bortezomib, Mitoxantrone Hydrochloride Liposome, and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Multi‐Center, Open‐Label Phase I Trial
Cancer Medicine·2025Open Access
Neonicotinoid and bisamide insecticides in wild freshwater fish from the Wanquan River, Hainan, China: Factors affecting tissue distribution and a risk assessment
Environmental Pollution·2025· 1 cited
Author Correction: lncRNA CHAF1B-2 contributes to the tumorigenesis of gastric cancer by activating the Wnt/β-catenin pathway
Scientific Reports·2025Open Access
Is t(11;14) in newly diagnosed multiple myeloma a favorable outcome in the novel agent era?
Blood Research·2025· 1 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Tongpeng Xu(11), Rui Xia(11), Euan K. James(10), Erbao Zhang(10), Janet I. Sprent(9), Wei De(9), Yongqian Shu(8), Shih‐Yi Sheu(8), Mingde Huang(7), Geoffrey N. Elliott(6), Ming Sun(6), Yin Wu(6), Jui-Hsing Chou(5), Ying Tian(5), J. Peter W. Young(4), Rong Kong(4), Guangzhong Yang(4), Peter Vandamme(3), Liang Han(3), Sérgio Miana de Faria(3)